Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 26 | $20,577,376 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
16 Nov 2023 19:24 | RCKT | ROCKET PHARMACEUTICALS Inc | MAKKER GOTHAM | Director | 15 Nov 2023 | Sale | 20,000 | 22.5323 | 450,646 | I |
23 Jan 2024 16:22 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 22 Jan 2024 | Sale | 638 | 27.203 | 17,356 | D |
21 Feb 2024 20:54 | RCKT | ROCKET PHARMACEUTICALS Inc | PATEL KINNARI | See Remarks | 16 Feb 2024 | Sale | 7,132 | 29.838 | 212,805 | D |
21 Feb 2024 20:54 | RCKT | ROCKET PHARMACEUTICALS Inc | WILSON MARTIN | General Counsel | 16 Feb 2024 | Sale | 3,576 | 29.838 | 106,701 | D |
21 Feb 2024 20:54 | RCKT | ROCKET PHARMACEUTICALS Inc | SHAH GAURAV | CEO | 16 Feb 2024 | Sale | 20,272 | 29.838 | 604,876 | D |
21 Feb 2024 20:54 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 16 Feb 2024 | Sale | 3,238 | 29.838 | 96,615 | D |
04 Mar 2024 18:54 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 29 Feb 2024 | Sale | 10,000 | 29.845 | 298,450 | D |
04 Mar 2024 18:48 | RCKT | ROCKET PHARMACEUTICALS Inc | WILSON MARTIN | General Counsel | 29 Feb 2024 | Sale | 4,100 | 29.331 | 120,257 | D |
10 Jun 2024 10:34 | RCKT | ROCKET PHARMACEUTICALS Inc | MAKKER GOTHAM | Director | 21 Mar 2024 | Sale A | 274,000 | 28.4341 | 7,790,943 | I |
25 Mar 2024 20:54 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 21 Mar 2024 | Sale | 2,490 | 28.104 | 69,979 | D |
25 Mar 2024 20:58 | RCKT | ROCKET PHARMACEUTICALS Inc | MAKKER GOTHAM | Director | 21 Mar 2024 | Sale | 274,000 | 28.4341 | 7,790,943 | I |
10 Apr 2024 20:39 | RCKT | ROCKET PHARMACEUTICALS Inc | WHITE MARK ANDREW | See Remarks | 08 Apr 2024 | Sale | 12,532 | 24.638 | 308,763 | D |
16 Apr 2024 17:45 | RCKT | ROCKET PHARMACEUTICALS Inc | SOUTHWELL DAVID P | Director | 12 Apr 2024 | Sale | 10,284 | 25.156 | 258,704 | D |
16 Apr 2024 17:45 | RCKT | ROCKET PHARMACEUTICALS Inc | SOUTHWELL DAVID P | Director | 12 Apr 2024 | Sale | 59,716 | 24.224 | 1,446,560 | D |
16 Apr 2024 17:45 | RCKT | ROCKET PHARMACEUTICALS Inc | SOUTHWELL DAVID P | Director | 15 Apr 2024 | Sale | 10,000 | 24.052 | 240,520 | D |
24 Apr 2024 16:06 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 22 Apr 2024 | Sale | 833 | 22.87 | 19,051 | D |
20 May 2024 16:36 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 16 May 2024 | Sale | 1,079 | 23.35 | 25,195 | D |
20 May 2024 16:29 | RCKT | ROCKET PHARMACEUTICALS Inc | WILSON MARTIN | General Counsel | 16 May 2024 | Sale | 1,048 | 23.35 | 24,471 | D |
20 May 2024 16:33 | RCKT | ROCKET PHARMACEUTICALS Inc | SHAH GAURAV | CEO | 16 May 2024 | Sale | 9,790 | 23.35 | 228,596 | D |
20 May 2024 16:26 | RCKT | ROCKET PHARMACEUTICALS Inc | PATEL KINNARI | See Remarks | 16 May 2024 | Sale | 4,046 | 23.35 | 94,474 | D |
09 Jul 2024 16:05 | RCKT | ROCKET PHARMACEUTICALS Inc | WHITE MARK ANDREW | See Remarks | 08 Jul 2024 | Sale | 3,026 | 20.395 | 61,715 | D |
24 Jul 2024 16:05 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 22 Jul 2024 | Sale | 812 | 23.015 | 18,688 | D |
20 Aug 2024 16:26 | RCKT | ROCKET PHARMACEUTICALS Inc | WILSON MARTIN | General Counsel | 16 Aug 2024 | Sale | 1,027 | 18.504 | 19,004 | D |
20 Aug 2024 16:26 | RCKT | ROCKET PHARMACEUTICALS Inc | PATEL KINNARI | See Remarks | 16 Aug 2024 | Sale | 3,989 | 18.504 | 73,812 | D |
20 Aug 2024 16:26 | RCKT | ROCKET PHARMACEUTICALS Inc | SHAH GAURAV | CEO | 16 Aug 2024 | Sale | 9,650 | 18.504 | 178,564 | D |
20 Aug 2024 16:26 | RCKT | ROCKET PHARMACEUTICALS Inc | MILITELLO JOHN | See Remarks | 16 Aug 2024 | Sale | 1,064 | 18.504 | 19,688 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)